XML 17 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Unaudited Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Income Statement [Abstract]              
Revenues $ 33,372 $ 21,698 $ 48,310 $ 28,647 $ 107,518 $ 76,434 $ 174,235
Cost of revenues (40,146) (18,144) (56,321) (23,875) (90,378) (76,665) (153,386)
Gross profit/(loss) (6,774) 3,554 (8,011) 4,772 17,140 (231) 20,849
Operating expenses:              
General and administrative expenses (6,178) (3,760) (10,752) (7,949) (18,849) (15,166) (34,229)
Research and development expenses (5,895) (4,242) (9,681) (7,960) (16,637) (25,995) (32,448)
Selling and marketing expenses (3,706) (2,686) (6,862) (6,008) (13,761) (15,712) (13,398)
Total operating expenses (15,779) (10,688) (27,295) (21,917) (49,247) (56,873) (80,075)
Subsidy income 213 650 2,131 841 3,000 3,243 9,538
Loss from operations (22,340) (6,484) (33,175) (16,304) (29,107) (53,861) (49,688)
Other income and expenses:              
Interest income 111 125 207 436 571 884 2,007
Interest expense (1,537) (1,357) (3,383) (2,837) (5,738) (6,352) (3,979)
Loss on changes in fair value of convertible notes (3,243) (6,843)        
Other (expense)/income, net 49 (4) 44 (5) 650 (145) (2,606)
Loss before provision for income taxes (26,960) (7,720) (43,150) (18,710) (33,624) (59,474) (54,266)
Income tax expense (109) (137) (218) (275) (1) (189) (6,425)
Net loss (27,069) (7,857) (43,368) (18,985) (33,625) (59,663) (60,691)
Less: Net loss attributable to noncontrolling interest         (2,123) (5,799)
Net loss attributable to Microvast, Inc. (27,069) (7,857) (43,368) (18,985) (33,625) (57,540) (54,892)
Less: Accretion of Series A1/C1 Preferred         3,897 4,102 10,025
Less: Accretion of Series B1/C2 Preferred         8,866 7,948 8,391
Less: Accretion of Series EEL/D1 Preferred         18,648 30,839 13,223
Less: Accretion of Series C1 Preferred 1,003 974 2,006 1,948      
Less: Accretion of Series C2 Preferred 2,281 2,217 4,562 4,434      
Less: Accretion of Series D1 Preferred 4,759 4,662 9,518 9,324      
Less: Accretion for noncontrolling interests 4,036 3,961 8,007 7,922 15,927 15,050 13,502
Net loss attributable to ordinary shareholders of Microvast, Inc. $ (39,148) $ (19,671) $ (67,461) $ (42,613) $ (80,963) $ (115,479) $ (100,033)
Net loss per share attributable to ordinary shareholders of Microvast, Inc.              
Basic and diluted (in Dollars per share) $ (63.36) $ (31.84) $ (109.18) $ (68.97) $ (131.03) $ (186.90) $ (161.90)
Weighted average shares used in calculating net loss per ordinary share              
Basic and diluted (in Shares) 617,880 617,880 617,880 617,880 617,880 617,880 617,880